Novozymes A/S (VIE:NZYM)
Austria flag Austria · Delayed Price · Currency is EUR
56.16
-1.06 (-1.85%)
At close: Nov 13, 2025

Novozymes Statistics

Total Valuation

Novozymes has a market cap or net worth of EUR 25.80 billion. The enterprise value is 28.63 billion.

Market Cap25.80B
Enterprise Value 28.63B

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date Nov 6, 2025
Ex-Dividend Date Aug 25, 2025

Share Statistics

Current Share Class 411.85M
Shares Outstanding n/a
Shares Change (YoY) -30.69%
Shares Change (QoQ) -0.92%
Owned by Insiders (%) 0.01%
Owned by Institutions (%) 27.23%
Float 346.32M

Valuation Ratios

The trailing PE ratio is 47.17 and the forward PE ratio is 26.44.

PE Ratio 47.17
Forward PE 26.44
PS Ratio 6.23
PB Ratio 2.40
P/TBV Ratio n/a
P/FCF Ratio 32.98
P/OCF Ratio 22.99
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.46, with an EV/FCF ratio of 36.59.

EV / Earnings 52.34
EV / Sales 6.91
EV / EBITDA 20.46
EV / EBIT 25.38
EV / FCF 36.59

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.29.

Current Ratio 1.61
Quick Ratio 0.98
Debt / Equity 0.29
Debt / EBITDA 2.21
Debt / FCF 3.97
Interest Coverage 16.62

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 7.50%
Revenue Per Employee 391,457
Profits Per Employee 51,692
Employee Count10,582
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Novozymes has paid 151.50 million in taxes.

Income Tax 151.50M
Effective Tax Rate 21.69%

Stock Price Statistics

The stock price has increased by +2.18% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +2.18%
50-Day Moving Average 53.46
200-Day Moving Average 56.57
Relative Strength Index (RSI) 55.88
Average Volume (20 Days) 0

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novozymes had revenue of EUR 4.14 billion and earned 547.00 million in profits. Earnings per share was 1.91.

Revenue4.14B
Gross Profit 2.43B
Operating Income 1.13B
Pretax Income 698.50M
Net Income 547.00M
EBITDA 1.40B
EBIT 1.13B
Earnings Per Share (EPS) 1.91
Full Income Statement

Balance Sheet

The company has 281.30 million in cash and 3.11 billion in debt, giving a net cash position of -2.83 billion.

Cash & Cash Equivalents 281.30M
Total Debt 3.11B
Net Cash -2.83B
Net Cash Per Share n/a
Equity (Book Value) 10.74B
Book Value Per Share 22.99
Working Capital 744.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.12 billion and capital expenditures -340.10 million, giving a free cash flow of 782.40 million.

Operating Cash Flow 1.12B
Capital Expenditures -340.10M
Free Cash Flow 782.40M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 58.55%, with operating and profit margins of 27.32% and 13.20%.

Gross Margin 58.55%
Operating Margin 27.32%
Pretax Margin 16.86%
Profit Margin 13.20%
EBITDA Margin 33.88%
EBIT Margin 27.32%
FCF Margin 18.89%

Dividends & Yields

This stock pays an annual dividend of 0.86, which amounts to a dividend yield of 1.54%.

Dividend Per Share 0.86
Dividend Yield 1.54%
Dividend Growth (YoY) 61.09%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 30.69%
Shareholder Yield 32.23%
Earnings Yield 2.12%
FCF Yield 3.03%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4